(2R)-2-[[1-[(2R,3R,4S,5S,6R)-3-fluoro-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]triazol-4-yl]methyl-(4-methoxyphenyl)sulfonylamino]-N-hydroxy-3-methylbutanamide

InChIKey	`TUYLXABAVZEOSZ-WGVHSKNFSA-N`
Compound Name	(2R)-2-[[1-[(2R,3R,4S,5S,6R)-3-fluoro-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]triazol-4-yl]methyl-(4-methoxyphenyl)sulfonylamino]-N-hydroxy-3-methylbutanamide
Canonical SMILES	`COc1ccc(S(=O)(=O)N(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)[C@@H](C(=O)NO)C(C)C)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	9.38
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P08253	MMP2	Homo sapiens	Human	PF00040 PF00045 PF00413	9.7	IC50	ChEMBL;BindingDB
P22894	MMP8	Homo sapiens	Human	PF00045 PF00413 PF01471	9.3	IC50	ChEMBL;BindingDB
P45452	MMP13	Homo sapiens	Human	PF00045 PF00413 PF01471	9.3	IC50	ChEMBL;BindingDB
P14780	MMP9	Homo sapiens	Human	PF00040 PF00045 PF00413	9.2	IC50	ChEMBL;BindingDB